The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology

[1] Spritzer PM(2014)Polycystic ovary syndrome Arq Bras Endocrinol Metab 58 182-187

[2] Moran LJ(2010)Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis Hum reprod update 16 347-363

[3] Misso ML(2016)Stein and Leventhal: 80 years on Am J Obstet Gynecol 214 247.e1-247.e11

[4] Wild RA(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 71 19-25

[5] Norman RJ(2009)The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertil Steril 91 456-488

[6] Azziz R(2016)Criteria, prevalence, and phenotypes of polycystic ovary syndrome Fertil Steril 106 6-15

[7] Adashi EY(2018)Role of AMH as diagnostic tool for polycystic ovarian syndrome J Obstet Gynaecol India 68 117-122

[8] Azziz R(2013)Elevated serum levels of anti-müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome Acta Obstet Gynecol Scand 92 1369-1374

[9] Carmina E(2010)A very large proportion of young Danish women have polycystic ovaries: is a revision of the rotterdam criteria needed? Hum Reprod 25 3117-3122

[10] Dewailly D(2014)Definition and significance of polycystic ovarian morphology: a task force report from the androgen excess and polycystic ovary syndrome society Hum Reprod Update 20 334-352

[1] Spritzer PM(2014)Polycystic ovary syndrome Arq Bras Endocrinol Metab 58 182-187

[2] Moran LJ(2010)Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis Hum reprod update 16 347-363

[3] Misso ML(2016)Stein and Leventhal: 80 years on Am J Obstet Gynecol 214 247.e1-247.e11

[4] Wild RA(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 71 19-25

[5] Norman RJ(2009)The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertil Steril 91 456-488

[6] Azziz R(2016)Criteria, prevalence, and phenotypes of polycystic ovary syndrome Fertil Steril 106 6-15

[7] Adashi EY(2018)Role of AMH as diagnostic tool for polycystic ovarian syndrome J Obstet Gynaecol India 68 117-122

[8] Azziz R(2013)Elevated serum levels of anti-müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome Acta Obstet Gynecol Scand 92 1369-1374

[9] Carmina E(2010)A very large proportion of young Danish women have polycystic ovaries: is a revision of the rotterdam criteria needed? Hum Reprod 25 3117-3122

[10] Dewailly D(2014)Definition and significance of polycystic ovarian morphology: a task force report from the androgen excess and polycystic ovary syndrome society Hum Reprod Update 20 334-352